SRNE - Sorrento Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.525
-0.075 (-2.885%)
As of 3:45PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close2.600
Open2.600
Bid2.500 x 13000
Ask2.550 x 8700
Day's Range2.425 - 2.700
52 Week Range1.500 - 7.130
Volume1,343,518
Avg. Volume1,023,761
Market Cap198.27M
Beta1.67
PE Ratio (TTM)-3.84
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 3 Biotech Stocks That Soared This Week: Are They Buys?
    Motley Fool5 days ago

    3 Biotech Stocks That Soared This Week: Are They Buys?

    Good news from clinical studies and a scrapped acquisition help powered these biotech stocks to huge gains this week.

  • Capital Cube9 days ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : October 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Investopedia14 days ago

    H.C. Wainwright Sees Over 1000% Upside for Sorrento Therapeutics (SRNE)

    H.C. Wainwright analyst Ram Selvaraju argues that Sorrento's PHN candidate can very well steal a "meaningful" slice of market share should approval be won.

  • Capital Cube2 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : September 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Sorrento Therapeutics, Inc. :SRNE-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube2 months ago

    Sorrento Therapeutics, Inc. :SRNE-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Sorrento Therapeutics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Sorrento Therapeutics, Inc. – Synergy Pharmaceuticals, Inc., Exelixis, Inc., Sucampo Pharmaceuticals, Inc. Class A and Karyopharm Therapeutics, Inc. (SGYP-US, EXEL-US, SCMP-US and KPTI-US) that have also reported for ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : June 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : June 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Sorrento Therapeutics, Inc. :SRNE-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
    Capital Cube5 months ago

    Sorrento Therapeutics, Inc. :SRNE-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017

    Categories: Yahoo FinanceGet free summary analysis Sorrento Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Sorrento Therapeutics, Inc. – Synergy Pharmaceuticals, Inc., Exelixis, Inc., Sucampo Pharmaceuticals, Inc. Class A and Karyopharm Therapeutics, Inc. (SGYP-US, EXEL-US, SCMP-US and KPTI-US) that have also reported for ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : May 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • 24/7 Wall St.6 months ago

    Sorrento Therapeutics Gears Up for Secondary Offering

    Sorrento Therapeutics saw its shares plunge on Thursday after the company announced a secondary offering.

  • Capital Cube6 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : April 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube7 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : March 30, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Sorrento Therapeutics, Inc. :SRNE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 24, 2017
    Capital Cube7 months ago

    Sorrento Therapeutics, Inc. :SRNE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 24, 2017

    Categories: Yahoo Finance Get free summary analysis Sorrento Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Sorrento Therapeutics, Inc. – Synergy Pharmaceuticals, Inc., Exelixis, Inc., Sucampo Pharmaceuticals, Inc. Class A and Karyopharm Therapeutics, Inc. (SGYP-US, EXEL-US, SCMP-US and KPTI-US) that have also reported for ... Read more (Read more...)

  • GuruFocus.com8 months ago

    Insider Buys Shares of Sorrento Therapeutics

    Company CEO invests in 20,000 shares

  • Jump in Insider Buying at Macquarie Infrastructure after Hedgeye Recommends Shorting the Stock, Spontaneous Insider Sale at Apple Inc. (AAPL), Plus Other Insider Trading
    Insider Monkey8 months ago

    Jump in Insider Buying at Macquarie Infrastructure after Hedgeye Recommends Shorting the Stock, Spontaneous Insider Sale at Apple Inc. (AAPL), Plus Other Insider Trading

    Insider trading behavior should constitute an important piece of data in one’s security analysis process, as past research shows that insider actions tend to offer an accurate reflection of the future prospects of companies, industries or even stock markets in general. Intuitively this makes perfect sense. After all, corporate insiders possess a broad set of […]

  • Capital Cube9 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : January 9, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Sorrento Therapeutics, Inc. – Value Analysis (NASDAQ:SRNE) : January 9, 2017
    Capital Cube9 months ago

    Sorrento Therapeutics, Inc. – Value Analysis (NASDAQ:SRNE) : January 9, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Sorrento Therapeutics, Inc. a score of 36. Our analysis is based on comparing Sorrento Therapeutics, Inc. with the following peers – Synergy Pharmaceuticals, Inc., Exelixis, Inc., Sucampo Pharmaceuticals, Inc. Class A and Karyopharm Therapeutics, Inc. (SGYP-US, EXEL-US, SCMP-US and KPTI-US). Investment Outlook Sorrento Therapeutics, Inc. has a ... Read more (Read more...)

  • Sorrento Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : SRNE-US : January 6, 2017
    Capital Cube9 months ago

    Sorrento Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : SRNE-US : January 6, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Sorrento Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • TheStreet.com10 months ago

    These 5 Stocks Under $10 Could Make You a Lot of Money

    Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

  • Capital Cube10 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : December 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube11 months ago

    ETFs with exposure to Sorrento Therapeutics, Inc. : November 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Sorrento Therapeutics, Inc. Here are 5 ETFs with the largest exposure to SRNE-US. Comparing the performance and risk of Sorrento Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Sorrento Therapeutics, Inc. :SRNE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016
    Capital Cube11 months ago

    Sorrento Therapeutics, Inc. :SRNE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016

    Categories: Yahoo Finance Get free summary analysis Sorrento Therapeutics, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Sorrento Therapeutics, Inc. – Synergy Pharmaceuticals, Inc., Exelixis, Inc., Sucampo Pharmaceuticals, Inc. Class A and Karyopharm Therapeutics, Inc. (SGYP-US, EXEL-US, SCMP-US and KPTI-US) that have also reported for ... Read more (Read more...)